Register entry
BTCP PHARMA LLC
- Registered sites
- 0
- Active NDC listings
- 0
- Live patents
- 71
- Countries
- 0
Exclusivity
Patents and exclusivities
71| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 10016403 | SUBSYSfentanyl | product | Jan 2027 |
| 10610523 | SUBSYSfentanyl | product | Jan 2027 |
| 8835459 | SUBSYSfentanyl | product | Jan 2027 |
| 8835460 | SUBSYSfentanyl | product | Jan 2027 |
| 9241935 | SUBSYSfentanyl | product | Jan 2027 |
| 9289387 | SUBSYSfentanyl | product | Jan 2027 |
| 9642797 | SUBSYSfentanyl | product | Jan 2027 |
| 9642844 | SUBSYSfentanyl | product | Jan 2027 |
| 8486972 | SUBSYSfentanyl | product | Apr 2030 |
| 8486973 | SUBSYSfentanyl | use | Apr 2030 |
| 9731869 | LAZANDAfentanyl citrate | product | Jan 2032 |
Enquiry
Common questions
- Is BTCP PHARMA LLC FDA approved?
- BTCP PHARMA LLC holds no registered establishment of its own; it appears here on its Orange Book patents.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.